Skip to main content
. 2015 Aug 3;2015:638645. doi: 10.1155/2015/638645

Figure 5.

Figure 5

Western blot analysis of specific proteins for validation of iTRAQ analysis (comparison of 25 : 1 n-3 : n-6 with 25 : 1 n-3 : n-6 plus Tamoxifen). (a) Lipoprotein E expression; (b) haptoglobin expression; (c) inter-α-inhibitor H4 heavy chain expression; * P ≤ 0.05. Reproduced with permission from [26].

HHS Vulnerability Disclosure